Improvements to scheduling and pharmacy care will support co-administration of flu vaccine and new reformulated COVID-19 boosters at more than 1,700 pharmacy locations.
Earlier this month, the FDA authorized state-licensed pharmacists to prescribe Paxlovid to eligible patients aged 12 years old and older, with certain limitations.
NACDS and NCPA commended the FDA for authorizing pharmacists to prescribe Paxlovid, but continue to urge the government to take action to ensure pharmacists are reimbursed for their services.
NACDS’ “Pharmacies. The face of neighborhood health care” campaign tells the story of pharmacies’ effectiveness in serving the American public during emergencies and every day.